当前位置: 首页 >> 检索结果
共有 539 条符合本次的查询结果, 用时 2.1509773 秒

341. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis.

作者: Mikael Mazighi.;Saqib A Chaudhry.;Marc Ribo.;Pooja Khatri.;David Skoloudik.;Maxim Mokin.;Julien Labreuche.;Elena Meseguer.;Sharon D Yeatts.;Adnan H Siddiqui.;Joseph Broderick.;Carlos A Molina.;Adnan I Qureshi.;Pierre Amarenco.
来源: Circulation. 2013年127卷19期1980-5页
Onset-to-reperfusion time has been reported to be associated with clinical prognosis. However, its impact on mortality remained to be assessed. Using a collaborative pooled analysis, we examined whether early mortality after successful endovascular treatment is time dependent.

342. Association of body mass index with major cardiovascular events and with mortality after percutaneous coronary intervention.

作者: Duk-Woo Park.;Young-Hak Kim.;Sung-Cheol Yun.;Jung-Min Ahn.;Jong-Young Lee.;Won-Jang Kim.;Soo-Jin Kang.;Seung-Whan Lee.;Cheol Whan Lee.;Seong-Wook Park.;Seung-Jung Park.
来源: Circ Cardiovasc Interv. 2013年6卷2期146-53页
Conflicting data exist regarding the relation between body mass index (BMI) and cardiovascular events and mortality after percutaneous coronary intervention.

343. Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis.

作者: Peter Ofman.;Owais Khawaja.;Catherine R Rahilly-Tierney.;Adelqui Peralta.;Peter Hoffmeister.;Mathew R Reynolds.;J Michael Gaziano.;Luc Djousse.
来源: Circ Arrhythm Electrophysiol. 2013年6卷2期252-6页
Although previous studies have suggested that competitive athletes have a higher risk of atrial fibrillation than the general population, limited and inconsistent data are available on the association between regular physical activity and the risk of atrial fibrillation.

344. Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients.

作者: Dean T Eurich.;Daniala L Weir.;Sumit R Majumdar.;Ross T Tsuyuki.;Jeffrey A Johnson.;Lisa Tjosvold.;Saskia E Vanderloo.;Finlay A McAlister.
来源: Circ Heart Fail. 2013年6卷3期395-402页
There is an ongoing controversy regarding the safety and effectiveness of metformin in the setting of heart failure (HF). Therefore, we undertook a systematic review of the trial and nontrial evidence for metformin in patients with diabetes mellitus and HF.

345. Quantifying the effect of cardiopulmonary resuscitation quality on cardiac arrest outcome: a systematic review and meta-analysis.

作者: Sarah K Wallace.;Benjamin S Abella.;Lance B Becker.
来源: Circ Cardiovasc Qual Outcomes. 2013年6卷2期148-56页
Background- Evidence has accrued that cardiopulmonary resuscitation quality affects cardiac arrest outcome. However, the relative contributions of chest compression components (such as rate and depth) to successful resuscitation remain unclear. Methods and Results- We sought to measure the effect of cardiopulmonary resuscitation quality on cardiac arrest outcome through systematic review and meta-analysis. We searched for any clinical study assessing cardiopulmonary resuscitation performance on adult cardiac arrest patients in which survival was a reported outcome, either return of spontaneous circulation or survival to admission or discharge. Of 603 identified abstracts, 10 studies met inclusion criteria. Effect sizes were reported as mean differences. Missing data were resolved by author contact. Estimates were segregated by cardiopulmonary resuscitation metric (chest compression rate, depth, no-flow fraction, and ventilation rate), and a random-effects model was applied to estimate an overall pooled effect. Arrest survivors were significantly more likely to have received deeper chest compressions than nonsurvivors (mean difference, 2.44 mm; 95% confidence interval, 1.19-3.69 [P<0.001]; n=6 studies; I(2)=0.0%; P for heterogeneity=0.9). Likewise, survivors were significantly more likely to have received chest compression rates closer to 85 to 100 compressions per minute (cpm) than nonsurvivors (absolute mean difference from 85 cpm, -4.81 cpm; 95% confidence interval, -8.19 to -1.43 [P=0.005]; from 100 cpm, -5.04 cpm; 95% confidence interval, -8.44 to -1.65 [P=0.004]; n=6 studies; I(2)<49%; P for heterogeneity >0.2). No significant difference in no-flow fraction (n=7 studies) or ventilation rate (n=4 studies) was detected between survivors and nonsurvivors. Conclusions- Deeper chest compressions and rates closer to 85 to 100 cpm are significantly associated with improved survival from cardiac arrest.

346. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis.

作者: Jorge Romero.;Syed Arman Husain.;Iosif Kelesidis.;Javier Sanz.;Hector M Medina.;Mario J Garcia.
来源: Circ Cardiovasc Imaging. 2013年6卷2期185-94页
Transesophageal echocardiogram (TEE) is considered the gold standard modality in detecting left atrial/LA appendage (LA/LAA) thrombi. However, this is a semi-invasive procedure with rare but potential life-threatening complications. Cardiac computed tomography has been proposed as an alternative method. The purpose of this meta-analysis was to evaluate the diagnostic accuracy of cardiac computed tomography assessing LA/LAA thrombi in comparison with TEE.

347. Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials.

作者: Srinivas R Bapoje.;Amit Bahia.;John E Hokanson.;Pamela N Peterson.;Paul A Heidenreich.;Joann Lindenfeld.;Larry A Allen.;Frederick A Masoudi.
来源: Circ Heart Fail. 2013年6卷2期166-73页
Sudden cardiac death (SCD) is an important cause of death in patients with left ventricular systolic dysfunction. Mineralocorticoid receptor antagonists (MRAs) may attenuate this risk. The objective of this meta-analysis was to assess the impact of MRAs on SCD in patients with left ventricular systolic dysfunction.

348. Impact of mineralocorticoid receptor antagonists on changes in cardiac structure and function of left ventricular dysfunction: a meta-analysis of randomized controlled trials.

作者: Xiaobo Li.;Yue Qi.;Yuqiong Li.;Shanshan Zhang.;Shujie Guo.;Shaoli Chu.;Pingjin Gao.;Dingliang Zhu.;Zhijun Wu.;Lin Lu.;Weifeng Shen.;Nan Jia.;Wenquan Niu.
来源: Circ Heart Fail. 2013年6卷2期156-65页
A comprehensive evaluation of the benefits of mineralocorticoid receptor antagonists on cardiac remodeling is lacking. We aimed to evaluate the impact of mineralocorticoid receptor antagonists on changes in cardiac structure and function of left ventricular dysfunction.

349. Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease.

作者: Sripal Bangalore.;Seema Pursnani.;Sunil Kumar.;Pantelis G Bagos.
来源: Circulation. 2013年127卷7期769-81页
Contemporary studies have shown that spontaneous but not procedural myocardial infarction (MI) is related to subsequent mortality. Whether percutaneous coronary intervention (PCI) reduces spontaneous (nonprocedural) MI is unknown.

350. A meta-analysis of aortic root size in elite athletes.

作者: Aline Iskandar.;Paul D Thompson.
来源: Circulation. 2013年127卷7期791-8页
The aorta is exposed to hemodynamic stress during exercise, but whether or not the aorta is larger in athletes is not clear. We performed a systematic literature review and meta-analysis to examine whethere athletes demonstrate increased aortic root dimensions compared with nonathlete controls.

351. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis.

作者: Matthew T James.;Susan M Samuel.;Megan A Manning.;Marcello Tonelli.;William A Ghali.;Peter Faris.;Merril L Knudtson.;Neesh Pannu.;Brenda R Hemmelgarn.
来源: Circ Cardiovasc Interv. 2013年6卷1期37-43页
Contrast-induced acute kidney injury (CI-AKI) has been associated with mortality, although it has been suggested this association may be attributable to confounding. We performed a systematic review and meta-analysis to characterize the associations between CI-AKI and subsequent clinical outcomes.

352. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies.

作者: Charalambos V Vlachopoulos.;Dimitrios G Terentes-Printzios.;Nikolaos K Ioakeimidis.;Konstantinos A Aznaouridis.;Christodoulos I Stefanadis.
来源: Circ Cardiovasc Qual Outcomes. 2013年6卷1期99-109页
Erectile dysfunction (ED) carries an independent risk for cardiovascular (CV) events. We conducted a meta-analysis of all longitudinal studies for determining the ability of ED to predict risk of clinical events and to dissect factors influencing this ability.

353. Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.

作者: Meng Lee.;Jeffrey L Saver.;Keun-Sik Hong.;Hsiu-Chuan Wu.;Bruce Ovbiagele.
来源: Circ Heart Fail. 2013年6卷2期287-92页
The risk-benefit profile of warfarin versus aspirin for patients with heart failure in normal sinus rhythm has not been definitively established. Our objective was to evaluate the overall comparative effects of warfarin and aspirin in patients with heart failure and normal sinus rhythm.

354. Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies.

作者: Bing Yu.;Maja Barbalic.;Ariel Brautbar.;Vijay Nambi.;Ron C Hoogeveen.;Weihong Tang.;Thomas H Mosley.;Jerome I Rotter.;Christopher R deFilippi.;Christopher J O'Donnell.;Sekar Kathiresan.;Ken Rice.;Susan R Heckbert.;Christie M Ballantyne.;Bruce M Psaty.;Eric Boerwinkle.; .
来源: Circ Cardiovasc Genet. 2013年6卷1期82-8页
High levels of cardiac troponin T, measured by a highly sensitive assay (hs-cTnT), are strongly associated with incident coronary heart disease and heart failure. To date, no large-scale genome-wide association study of hs-cTnT has been reported. We sought to identify novel genetic variants that are associated with hs-cTnT levels.

355. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies.

作者: Lu Wang.;Yiqing Song.;Joann E Manson.;Stefan Pilz.;Winfried März.;Karl Michaëlsson.;Annamari Lundqvist.;Simerjot K Jassal.;Elizabeth Barrett-Connor.;Cuilin Zhang.;Charles B Eaton.;Heidi T May.;Jeffrey L Anderson.;Howard D Sesso.
来源: Circ Cardiovasc Qual Outcomes. 2012年5卷6期819-29页
Vitamin D status has been linked to the risk of cardiovascular disease (CVD). However, the optimal 25-hydroxy-vitamin D (25[OH]-vitamin D) levels for potential cardiovascular health benefits remain unclear.

356. Why does primary angioplasty not work in registries? Quantifying the susceptibility of real-world comparative effectiveness data to allocation bias.

作者: Sayan Sen.;Justin E Davies.;Iqbal S Malik.;Rodney A Foale.;Ghada W Mikhail.;Nearchos Hadjiloizou.;Alun Hughes.;Jamil Mayet.;Darrel P Francis.
来源: Circ Cardiovasc Qual Outcomes. 2012年5卷6期759-66页
Meta-analysis of registries (comparative effectiveness research) shows that primary angioplasty and fibrinolysis have equivalent real-world survival. Yet, randomized, controlled trials consistently find primary angioplasty superior. Can unequal allocation of higher-risk patients in registries have masked primary angioplasty benefit?

357. Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.

作者: Kenji Sakata.;Katsuhisa Waseda.;Teruyoshi Kume.;Hiromasa Otake.;Daisaku Nakatani.;Paul G Yock.;Peter J Fitzgerald.;Yasuhiro Honda.
来源: Circ Cardiovasc Interv. 2012年5卷6期763-71页
Exaggerated neointimal hyperplasia is considered as the primary mechanism for increased restenosis in patients with diabetes mellitus (DM) treated with bare-metal stent. However, the vessel response in DM and non-DM treated with different drug-eluting stents (DES) has not been systematically evaluated.

358. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.

作者: Sradha Kotwal.;Min Jun.;David Sullivan.;Vlado Perkovic.;Bruce Neal.
来源: Circ Cardiovasc Qual Outcomes. 2012年5卷6期808-18页
Early trials evaluating the effect of omega 3 fatty acids (ω-3 FA) reported benefits for mortality and cardiovascular events but recent larger studies trials have variable findings. We assessed the effects of ω-3 FA on cardiovascular and other important clinical outcomes.

359. Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis.

作者: Crystal E Tan.;Stanton A Glantz.
来源: Circulation. 2012年126卷18期2177-83页
Secondhand smoke causes cardiovascular and respiratory disease. Smoke-free legislation is associated with a lower risk of hospitalization and death from these diseases.

360. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

作者: Francesco Dentali.;Nicoletta Riva.;Mark Crowther.;Alexander G G Turpie.;Gregory Y H Lip.;Walter Ageno.
来源: Circulation. 2012年126卷20期2381-91页
Novel oral anticoagulants (NOACs) have been proposed as alternatives to vitamin K antagonists for the prevention of stroke and systemic embolism in patients with atrial fibrillation. Individually, NOACs were at least noninferior to vitamin K antagonists, but a clear superiority in overall and vascular mortality was not consistently proven.
共有 539 条符合本次的查询结果, 用时 2.1509773 秒